Full-Time

ACO Quality Specialist

Memorial Hermann

Memorial Hermann

10,001+ employees

Integrated health system delivering patient-centered care

No salary listed

Houston, TX, USA

In Person

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Electronic Health Records (EHR)
Excel/Numbers/Sheets

Get referred to Memorial Hermann

See people who can refer or advise you

Requirements
  • A high school diploma or GED is required.
  • A degree or certification in healthcare is required; acceptable examples include Medical Assistant, Licensed Vocational Nurse, Pharmacy Technician, Bachelor of Social Work, Health Coach, or Coder.
  • Three years of healthcare-related experience is required.
  • Experience working directly with patients, physicians, and other interdisciplinary care team members is required.
  • Proficiency in word processing and Excel software, with basic knowledge of database applications, is required.
  • Effective oral and written communication skills are required.
  • The ability to manage multiple tasks and priorities simultaneously is required.
Responsibilities
  • Serve as a member of the ACO/PHSO Quality team.
  • Provide data and resources to practitioners and care team members for managing population groups and individual patients to reach quality goals and maximize quality outcomes.
  • Assist patients and physicians with addressing gaps in care for contracted payer populations.
  • Provide outreach to patients, families, and physicians in accordance with goals set within contractual and clinical outcome metrics.
  • Manage payer files and Excel worksheets to track outcomes.
  • Conduct claims research and audit medical records to demonstrate performance against payer contract performance metrics.
  • Participate in special projects such as member outreach initiatives.
  • Take ownership of specific projects or endeavors to reach desired outcomes at both macro and micro levels as needed.
  • Participate in performance improvement activities.
  • Ensure safe care for patients, staff, and visitors and adhere to organizational policies, procedures, and standards within budgetary specifications, including time management, supply management, productivity, and quality of service.
  • Meet requirements for mandatory and continuing education and skills competency, support department-based goals, and serve as a preceptor, mentor, and resource to less experienced staff.
  • Create compassionate and personalized experiences for community members, patients, and colleagues while modeling service standards.
  • Perform other duties as assigned.
Desired Qualifications
  • Experience with data support.
  • Experience with electronic medical records software.

Memorial Hermann Health System is a nonprofit, community-owned health system serving the Greater Houston area with more than 260 care delivery sites. It delivers safe, high-quality, patient-centered care through an integrated network that combines clinical expertise with advanced technology. The system differentiates itself through its community ownership, value-driven culture, and broad network of hospitals, clinics, and specialty services. Its goal is to improve regional health outcomes by providing comprehensive, accessible care and leveraging innovation to personalize treatment.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5M

Headquarters

Houston, Texas

Founded

1907

Get referred to Memorial Hermann

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 16, 2026 Helix Genomic Advantage gives employees clinical genomic screening and targeted care.
  • June 2026 Texas funded Memorial Hermann $750,000 to add a second mobile stroke unit.
  • HEAL High School reopened August 2026 with simulated hospital training and paid apprenticeships.

What critics are saying

  • Memorial Hermann will terminate commercial health plans by end-2027 after solvency concerns.
  • Federal prosecutors indicted transplant director John Bynon in February 2026; families still sue.
  • The September 2025 hidden-camera class action threatens reputation and trial expenses in 2026.

What makes Memorial Hermann unique

  • Memorial Hermann pioneered America’s first mobile stroke unit in 2014, now expanding it in 2026.
  • TIRR Memorial Hermann ranked No. 1 Texas rehabilitation hospital in 2026-2027 U.S. News.
  • GenoME and Helix Genomic Advantage embed population genomics into workforce care and research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Wellness Program

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

14%

1 year growth

14%

2 year growth

14%
The Business Journals
Aug 19th, 2026
Former Houston transplant surgeon's federal case moves toward trial.

Former Houston transplant surgeon's federal case moves toward trial. By Megan Reyna - KHOU 11 Aug 19, 2026 Preview this article 1 min Dr. John Stevenson Bynon, 66, the former surgical director of liver transplantation at Memorial Hermann, is accused of falsifying medical records. Don't Stop Here - Continue Reading For $1 Per Week Secure 4 weeks of award-winning news and trusted insights Subscribe for only $4

AllSci
Jul 8th, 2026
Helix secures AstraZeneca partnership to power drug discovery with US genomic data.

Helix secures AstraZeneca partnership to power drug discovery with US genomic data. July 8, 2026 AstraZeneca has signed a multi-year agreement with San Mateo-based Helix to access its GenoSphere clinico-genomic cohort platform for drug discovery and development, adding a major US commercial data source to its existing population genomics infrastructure. The deal gives AstraZeneca (Nasdaq: AZN) access to Helix's continuously growing, deeply phenotyped cohorts spanning cardiometabolic, respiratory, and autoimmune disease areas. The agreement is AstraZeneca's latest move in a systematic multi-source genomics strategy and arrives as Helix establishes itself as a recurring platform partner to top-tier pharma. Financial terms were not disclosed. GenoSphere cohorts combine Exome+ genomic sequencing with longitudinal electronic health record data averaging 13 years of follow-up per patient, drawn from the Helix Research Network - described by the company as the largest precision health network in North America. The datasets are de-identified and fully consented, with the option to launch targeted follow-on studies. The platform is designed to support target identification, disease biology research, and patient stratification across the drug development lifecycle, functioning as a discovery infrastructure layer rather than a single-indication tool. Helix recently launched its Genomic Advantage program with Nebraska Medicine and Memorial Hermann Health System, adding new health system partners that feed the underlying research network. For AstraZeneca, the Helix deal adds a commercially managed, US-based, exome-sequenced cohort to a genomics portfolio that already includes co-funded access to the UK Biobank whole-genome sequencing dataset and membership in the Alliance for Genomic Discovery - a consortium that includes AbbVie, Amgen, GSK, Merck, and Novo Nordisk, among others. AstraZeneca's Centre for Genomics Research has publicly stated a goal of analyzing 2 million genomes by 2026. The Helix agreement adds a North American commercial data layer to AstraZeneca's existing European biobank partnerships. Helix previously signed a multi-year collaboration with GSK, announced in January 2026 using an identical structural template, with AstraZeneca now the third major pharma to sign onto the same GenoSphere platform following Helix's March 2026 agreement with Alnylam Pharmaceuticals. This article was generated with AI assistance and reviewed and edited by the AllSci editorial team Explore more at AllSci News: https://allsci.com/news/

Business Wire
Jun 23rd, 2026
Cadence Raises $100M Series C Led by Spark Capital to Automate Chronic Care

Cadence, the clinical AI company managing chronic care for older adults, announced a $100 million Series C, amid adoption of its AI-powered care model across...

PR Newswire
Jun 16th, 2026
Two US health systems launch Helix Genomic Advantage to cut costs through precision medicine

Nebraska Medicine and Memorial Hermann Health System have launched Helix Genomic Advantage, integrating clinical-grade genomic insights into care delivery for their workforces. The programme follows a similar launch with St. Luke's University Health Network. Both health systems are Helix Research Network partners operating large-scale community genomics studies. The Genomic Advantage model aims to implement precision medicine for targeted populations whilst reducing costs, addressing the high expense that has historically prevented scaling diagnostic genomics. "The high cost of diagnostic genomics has served as a significant barrier, preventing health systems from scaling these insights for patient populations," said James Lu, Helix CEO and co-founder. The programme aligns incentives to drive expanded access and total cost of care reduction across risk-based populations.

McIlroy Insurance Group
Jun 16th, 2026
Memorial Hermann Is Leaving the Houston Market. Here's What Every Business Owner and HR Manager Needs to Know

Memorial Hermann Is Leaving the Houston Market. Here's What Every Business Owner and HR Manager Needs to Know